NRX Pharmaceuticals, Inc. - Quarter Report: 2019 June (Form 10-Q)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 10-Q
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the
quarterly period ended June 30, 2019
or
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the
transition period
from __________ to __________
Commission
File Number: 001-38302
BIG ROCK PARTNERS ACQUISITION CORP.
(Exact
name of registrant as specified in its charter)
Delaware
|
82-2844431
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
Number)
|
2645 N. Federal Highway, Suite 230
Delray Beach, FL
|
33483
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (310) 734-2300
N/A
(Former
name, former address and former fiscal year if changed since last
report)
Securities
registered pursuant to section 12(b) of the
Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on
which registered
|
Units,
each consisting of one share of Common Stock, one Right and
one-half of one Warrant
|
|
BRPAU
|
|
The
NASDAQ Stock Market LLC
|
Common
Stock, par value $0.001 per share
|
|
BRPA
|
|
The
NASDAQ Stock Market LLC
|
Rights,
exchangeable into one-tenth of one share of Common
Stock
|
|
BRPAR
|
|
The
NASDAQ Stock Market LLC
|
Warrants,
each whole warrant exercisable for one share of Common Stock at an
exercise price of $11.50
|
|
BRPAW
|
|
The
NASDAQ Stock Market LLC
|
Indicate
by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes ☒ No
☐
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Date File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during
the preceding 12 months (or for such shorter period that the
registrant was required to submit such
files). Yes ☒
No ☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the
definitions of “large accelerated filer,”
“accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large
accelerated filer ☐
|
|
Accelerated
filer ☐
|
Non-accelerated
filer ☒
|
|
Smaller
reporting company ☒
|
|
|
Emerging
growth company ☒
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). Yes
☒
No ☐
As of
August 14, 2019, there were 6,915,728 shares of the Company’s
common stock, par value $0.001, issued and
outstanding.
TABLE OF CONTENTS
PART
I.
|
FINANCIAL
INFORMATION
|
1
|
|
|
|
ITEM
1.
|
FINANCIAL
STATEMENTS
|
1
|
|
|
|
|
Condensed Balance
Sheets
|
1
|
|
|
|
|
Condensed
Statements of Operations
|
2
|
|
|
|
|
Condensed
Statements of Changes in Stockholders’ Equity
|
3
|
|
|
|
|
Condensed
Statements of Cash Flows
|
4
|
|
|
|
|
Notes
to Condensed Financial Statements
|
5
|
|
|
|
ITEM
2.
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
10
|
|
|
|
ITEM
3.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
13
|
|
|
|
ITEM
4.
|
CONTROLS
AND PROCEDURES
|
13
|
|
|
|
PART
II.
|
OTHER
INFORMATION
|
14
|
|
|
|
ITEM
1.
|
LEGAL
PROCEEDINGS
|
14
|
|
|
|
ITEM
1A.
|
RISK
FACTORS
|
14
|
|
|
|
ITEM
2.
|
UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
14
|
|
|
|
ITEM
3.
|
DEFAULTS
UPON SENIOR SECURITIES
|
14
|
|
|
|
ITEM
4.
|
MINE
SAFETY DISCLOSURES
|
14
|
|
|
|
ITEM
5.
|
OTHER
INFORMATION
|
14
|
|
|
|
ITEM
6.
|
EXHIBITS
|
15
|
|
|
|
SIGNATURES
|
16
|
P ART I - FINANCIAL INFORMATION
I TEM 1. FINANCIAL STATEMENTS
BIG ROCK PARTNERS ACQUISITION CORP.
Condensed Balance Sheets
|
June 30,
2019
|
December 31,
2018
|
|
(Unaudited)
|
|
ASSETS
|
|
|
Current
Assets
|
|
|
Cash
|
$1,394
|
$11,079
|
Prepaid expenses
and other current assets
|
39,883
|
19,114
|
Total Current
Assets
|
41,277
|
30,193
|
|
|
|
Cash and marketable
securities held in Trust Account
|
50,061,450
|
70,765,966
|
Total
Assets
|
$50,102,727
|
$70,796,159
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
Current
liabilities
|
|
|
Accounts payable
and accrued expenses
|
$432,448
|
$551,099
|
Income taxes
payable
|
88,703
|
16,311
|
Total Current
Liabilities
|
521,151
|
567,410
|
|
|
|
Promisorry note -
related party
|
206,865
|
—
|
Promissory notes
payable
|
1,380,000
|
690,000
|
Total
Liabilities
|
2,108,016
|
1,257,410
|
|
|
|
Commitments
and Contingencies (Note 5)
|
|
|
|
|
|
Common stock
subject to possible redemption, 4,114,378 and 6,310,461 shares at
redemption value as of June 30, 2019 and December 31, 2018,
respectively
|
42,994,703
|
64,538,743
|
|
|
|
Stockholders’
Equity
|
|
|
Preferred stock,
$0.001 par value; 1,000,000 authorized; none issued and
outstanding
|
—
|
—
|
Common stock,
$0.001 par value; 100,000,000 shares authorized; 2,801,350 and
2,725,039 shares issued and outstanding (excluding 4,114,378 and
6,310,461 shares subject to possible redemption) as of June 30,
2019 and December 31, 2018, respectively
|
2,801
|
2,725
|
Additional paid-in
capital
|
4,672,153
|
5,036,213
|
Retained
earnings/(Accumulated deficit)
|
325,054
|
(38,932)
|
Total
Stockholders’ Equity
|
5,000,008
|
5,000,006
|
TOTAL
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$50,102,727
|
$70,796,159
|
The
accompanying notes are an integral part of the condensed financial
statements.
1
BIG ROCK PARTNERS ACQUISITION CORP.
Condensed Statements of Operations
(Unaudited)
|
Three Months Ended
June 30,
|
Six Months
Ended
June
30,
|
||
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
Operating
expenses
|
$175,742
|
$271,810
|
$338,923
|
$464,184
|
Loss
from operations
|
(175,742)
|
(271,810)
|
(338,923)
|
(464,184)
|
|
|
|
|
|
Other
income:
|
|
|
|
|
Interest
income
|
392,439
|
272,482
|
775,301
|
486,051
|
Unrealized gain on
marketable securities held in Trust Account
|
—
|
1,674
|
—
|
75
|
Other income,
net
|
392,439
|
274,156
|
775,301
|
486,126
|
|
|
|
|
|
Income before
provision for income taxes
|
216,697
|
2,346
|
436,378
|
21,942
|
Provision for
income taxes
|
(40,676)
|
(8,948)
|
(72,392)
|
(13,063)
|
Net
income (loss)
|
$176,021
|
$(6,602)
|
$363,986
|
$8,879
|
|
|
|
|
|
Weighted average
shares outstanding, basic and diluted (1)
|
2,794,297
|
2,605,782
|
2,759,859
|
2,598,424
|
|
|
|
|
|
Basic
and diluted net loss per common share (2)
|
$(0.03)
|
$(0.06)
|
$(0.06)
|
$(0.13)
|
(1)
|
Excludes
an aggregate of up to 4,114,378 and 6,412,916 shares subject to
possible redemption at June 30, 2019 and 2018,
respectively.
|
(2)
|
Net
loss per common share - basic and diluted excludes income
attributable to common stock subject to possible redemption of
$259,727 and $158,321 for the three months ended June 30, 2019 and
2018, respectively, and $518,924 and $355,325, for the six months
ended June 30, 2019 and 2018, respectively.
|
The
accompanying notes are an integral part of the condensed financial
statements.
2
BIG ROCK PARTNERS ACQUISITION CORP.
Condensed Statements of Changes in Stockholders’
Equity
(Unaudited)
Three Months Ended June 30, 2018
|
Common
Stock
|
Additional
Paid-in
|
Accumulated
|
Total
Stockholders’
|
|
|
Shares
|
Amount
|
Capital
|
Deficit
|
Equity
|
Balance –
January 1, 2018
|
2,590,985
|
$2,591
|
$5,102,443
|
$(105,033)
|
$5,000,001
|
|
|
|
|
|
|
Change in value of common stock
subject to possible redemption
|
14,797
|
15
|
(15,492)
|
—
|
(15,477)
|
|
|
|
|
|
|
Net income
|
—
|
—
|
—
|
15,481
|
15,481
|
|
|
|
|
|
|
Balance –
March 31, 2018 (unaudited)
|
2,605,782
|
2,606
|
5,086,951
|
(89,552)
|
5,000,005
|
|
|
|
|
|
|
Change in value of common stock
subject to possible redemption
|
16,802
|
17
|
6,589
|
—
|
6,606
|
|
|
|
|
|
|
Net income
|
—
|
—
|
—
|
(6,602)
|
(6,602)
|
|
|
|
|
|
|
Balance –
June 30, 2018 (unaudited)
|
2,622,584
|
$2,623
|
$5,093,540
|
$(96,154)
|
$5,000,009
|
Three Months Ended June 30, 2019
|
Common
Stock
|
Additional
Paid-in
|
Retained
Earnings/ (Accumulated
|
Total
Stockholders’
|
|
|
Shares
|
Amount
|
Capital
|
Deficit)
|
Equity
|
Balance –
January 1, 2019
|
2,725,039
|
$2,725
|
$5,036,213
|
$(38,932)
|
$5,000,006
|
|
|
|
|
|
|
Change in value of common stock
subject to possible redemption
|
69,258
|
69
|
(188,035)
|
—
|
(187,966)
|
|
|
|
|
|
|
Net income
|
—
|
—
|
—
|
187,965
|
187,965
|
|
|
|
|
|
|
Balance –
March 31, 2019 (unaudited)
|
2,794,297
|
2,794
|
4,848,178
|
149,033
|
5,000,005
|
|
|
|
|
|
|
Change in value of common stock
subject to possible redemption
|
7,053
|
7
|
(367,234)
|
—
|
(367,227)
|
|
|
|
|
|
|
Capital contribution to Trust
Account to extend the date by which the Company is required to
consummate a Business Combination
|
—
|
—
|
191,209
|
—
|
191,209
|
|
|
|
|
|
|
Net income
|
—
|
—
|
—
|
176,021
|
176,021
|
|
|
|
|
|
|
Balance –
June 30, 2019 (unaudited)
|
2,801,350
|
$2,801
|
$4,672,153
|
$325,054
|
$5,000,008
|
The
accompanying notes are an integral part of the condensed financial
statements.
3
BIG ROCK PARTNERS ACQUISITION CORP.
Condensed Statements of Cash Flows
(Unaudited)
|
Six Months Ended
June 30,
|
|
|
2019
|
2018
|
Cash
Flows from Operating Activities:
|
|
|
Net
income
|
$363,986
|
$8,879
|
Adjustments to
reconcile net income to net cash used in operating
activities:
|
|
|
Interest earned on
cash and marketable securities held in Trust Account
|
(775,301)
|
(486,051)
|
Unrealized gain on
marketable securities held in Trust Account
|
—
|
(75)
|
Changes in
operating assets and liabilities:
|
|
|
Prepaid expenses
and other current assets
|
(20,769)
|
10,569
|
Accounts payable
and accrued expenses
|
(118,651)
|
118,715
|
Income taxes
payable
|
72,392
|
13,063
|
Net
cash used in operating activities
|
(478,343)
|
(334,900)
|
|
|
|
Cash
Flows from Investing Activities:
|
|
|
Cash withdrawn from
Trust Account
|
22,099,233
|
—
|
Investment of cash
in Trust Account
|
(690,000)
|
—
|
Cash withdrawn from
Trust Account to pay franchise taxes
|
261,793
|
32,639
|
Net
cash provided by investing activities
|
21,671,026
|
32,639
|
|
|
|
Cash
Flows from Financing Activities:
|
|
|
Proceeds from
promissory notes
|
690,000
|
—
|
Proceeds from
promissory note - related party
|
271,865
|
—
|
Repayment of
promissory note - related party
|
(65,000)
|
—
|
Redemption of
common stock
|
(22,099,233)
|
—
|
Payment of offering
costs
|
—
|
(7,500)
|
Net
cash used in financing activities
|
(21,202,368)
|
(7,500)
|
|
|
|
Net
Change in Cash
|
(9,685)
|
(309,761)
|
Cash –
Beginning
|
11,079
|
449,374
|
Cash
– Ending
|
$1,394
|
$139,613
|
|
|
|
Non-Cash
Investing and Financing activities:
|
|
|
Change in value of
common stock subject to possible redemption
|
$555,193
|
$8,871
|
Capital
contribution to Trust Account
|
$191,209
|
$—
|
The
accompanying notes are an integral part of the condensed financial
statements.
4
BIG ROCK PARTNERS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2019
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
Big
Rock Partners Acquisition Corp. (the “Company”) is a
blank check company incorporated in Delaware on September 18, 2017.
The Company was formed for the purpose of acquiring, through a
merger, share exchange, asset acquisition, stock purchase,
reorganization, recapitalization, or other similar business
transaction, one or more operating businesses or entities (a
“Business Combination”). Although the Company is not
limited to a particular industry or geographic region for purposes
of consummating a Business Combination, the Company is focusing on
businesses in the senior housing and care industry in the United
States.
All
activity through June 30, 2019 relates to the Company’s
formation, the initial public offering (the “Initial Public
Offering”) of 6,900,000 units (the “Units”) that
occurred on November 22, 2017, the simultaneous sale of 272,500
units (the “Private Placement Units”) in a private
placement to Big Rock Partners Sponsor, LLC (the
“Sponsor”), and the Company’s search for a target
business with which to complete a Business
Combination.
The
Company initially had until November 22, 2018 to complete a
Business Combination. However, if the Company anticipated that it
could not consummate a Business Combination by November 22, 2018,
the Company could extend the period of time to consummate a
Business Combination up to two times, each by an additional three
months (for a total of up to 18 months to complete a Business
Combination) (the “Combination Period”). Pursuant to
the terms of the Company's Amended and Restated Certificate of
Incorporation and the trust agreement entered into between the
Company and Continental Stock Transfer & Trust Company on
November 20, 2017, in order to extend the time available for the
Company to consummate a Business Combination, the Sponsor or its
affiliates or designees were required to deposit into the Trust
Account $690,000 ($0.10 per share) for each three month extension,
up to an aggregate of $1,380,000, or $0.20 per share, if the
Company extended for the full six months, on or prior to the date
of the applicable deadline.
On
November 20, 2018, the period of time for the Company to consummate
a Business Combination was extended for an additional three month
period ending on February 22, 2019, and, accordingly, $690,000 was
deposited into the Trust Account. The deposit was funded by a
non-interest bearing unsecured promissory note from BRAC Lending
Group LLC, an affiliate of the underwriter (the
“Investor”)(see Note 4). The note is repayable upon the
consummation of a Business Combination (see Note 4). On February
21, 2019, the Company further extended the time required to
consummate a Business Combination to May 22, 2019 and deposited an
additional $690,000 into the Trust Account.
On May
21, 2019, the Company’s stockholders approved an amendment to
its Amended and Restated Certificate of Incorporation to extend the
period of time for which the Company is required to consummate a
Business Combination to August 22, 2019 (the “Extended
Date”). The number of shares of common stock presented for
redemption in connection with the extension was 2,119,772. The
Company paid cash in the aggregate amount of $22,099,233, or
approximately $10.43 per share, to redeeming stockholders. The
Company agreed to deposit, or cause to be deposited on its behalf,
into the Trust Account $0.02 for each public share outstanding for
each 30-day extension period utilized through the Extended Date.
Through June 30, 2019, the Company deposited an aggregate of
$191,209 into the Trust Account, which was contributed to the
Trust Account by a third party and is not required to be repaid by
the Company. Accordingly, the Company has recorded this amount as a
credit to additional paid in capital in the accompanying condensed
statements of stockholders’ equity. In July 2019, the Company
deposited an additional $95,605 into the Trust Account for the
third, and final, 30-day extension period. The Company now has
until August 22, 2019 to consummate a Business Combination (see
Note 7). In order to pay for part of the third extension payment,
the Company issued an unsecured promissory note (the
“Note”) in favor of the Investor, in the original
principal amount of $6,814. The Note does not bear interest and
matures upon closing of a Business Combination by the Company. If
the Company fails to consummate a Business Combination, the
outstanding debt under the Note will be forgiven, except to the
extent of any funds held outside of the Company's Trust Account
after paying all other fees and expenses of the
Company.
The
Company has scheduled a special meeting of stockholders for August
21, 2019, pursuant to which it will seek stockholder approval to,
among other matters, amend the Company’s Amended and Restated
Certificate of Incorporation to extend the period of time for which
the Company is required to consummate a Business Combination from
August 22, 2019 to November 22, 2019. There is no assurance that
the Company’s stockholders will vote to approve the extension
of time with which the Company has to complete a Business
Combination. If the Company does not obtain stockholder approval,
the Company would wind up its affairs and liquidate (see Note
7).
NASDAQ Notification
On
January 7, 2019, the Company received a notice from the staff of
the Listing Qualifications Department of Nasdaq (the
“Staff”) stating that the Company was no longer in
compliance with Nasdaq Listing Rule 5620(a) for continued listing
due to its failure to hold an annual meeting of stockholders within
twelve months of the end of the Company’s fiscal year ended
December 31, 2017. The Company submitted a plan of compliance with
Nasdaq and Nasdaq granted the Company an extension until May 22,
2019 to regain compliance with the rule by holding an annual
meeting of stockholders. The Company held its annual meeting of
stockholders on May 21, 2019 and, accordingly, the Staff determined
that the Company is currently in compliance with Nasdaq Listing
Rule 5620(a) for continued listing and the matter was
closed.
On
August 9, 2019, the Company received a notice from the Staff
stating that the Company was no longer in compliance with Nasdaq
Listing Rule 5550(a)(3) for continued listing due to its failure to
maintain a minimum of 300 public holders. The Company has
until
September 23, 2019 to provide Nasdaq with a specific plan to
achieve and sustain compliance with the listing requirement. The
notice is a notification of deficiency, not of imminent delisting,
and has no current effect on the listing or trading of the
Company's securities on Nasdaq.
The
Company intends to submit a plan to regain compliance within the
required timeframe. If Nasdaq accepts the Company's plan, Nasdaq
may grant the Company an extension of up to 180 calendar days from
the date of the notice to evidence compliance with the Rule. If
Nasdaq does not accept the Company's plan, the Company will have
the opportunity to appeal the decision in front of a Nasdaq
Hearings Panel.
5
BIG ROCK PARTNERS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2019
(Unaudited)
NOTE 2. LIQUIDITY
As of
June 30, 2019, the Company had $1,394 in its operating bank
account, $50,061,450 in cash and marketable securities held in the
Trust Account to be used for a Business Combination or to
repurchase or convert stock in connection therewith and a working
capital deficit of $371,171, which excludes franchise and income
taxes payable of $108,703, of which such amounts will be paid from
interest earned on the Trust Account. As of June 30, 2019,
approximately $1,112,000 of the amount on deposit in the Trust
Account represented interest income, which is available to pay the
Company’s tax obligations. To date, the Company has withdrawn
approximately $304,000 of interest from the Trust Account in order
to pay the Company’s taxes, of which approximately $262,000
was withdrawn during the six months ended June 30,
2019.
On
November 17, 2018, the Company entered into an agreement (the
“Agreement”) with the Sponsor and the Investor,
pursuant to which the Sponsor agreed to be responsible for all
liabilities of the Company as of November 17, 2018 and to loan the
Company the funds necessary to pay the expenses of the Company
other than Business Combination expenses through the closing of a
Business Combination when and as needed. If a Business Combination
is not consummated, all outstanding loans made by the Sponsor will
be forgiven (see Note 4). In addition, the Investor agreed to loan
the Company all funds necessary to pay expenses incurred in
connection with and in order to consummate a business combination
(the “Business Combination Expenses”) and such loans
will be added to the Notes (as defined in Note 4). If the Company
does not consummate a Business Combination, all outstanding loans
under the Notes will be forgiven, except to the extent of any funds
held outside of the Trust Account after paying all other fees and
expenses of the Company incurred prior to the date of such failure
to consummate a Business Combination (see Note 4).
The
Company may raise additional capital through loans or additional
investments from the Sponsor or its stockholders, officers,
directors, or third parties. Other than as described above, the
Company’s officers and directors and the Sponsor may, but are
not obligated to, loan the Company funds, from time to time, in
whatever amount they deem reasonable in their sole discretion, to
meet the Company’s working capital needs.
The
Company does not believe it will need to raise additional funds in
order to meet expenditures required for operating its business.
Neither the Sponsor, nor any of the stockholders, officers or
directors, or third parties are under any obligation to advance
funds to, or invest in, the Company, except as discussed above.
Accordingly, the Company may not be able to obtain additional
financing. If the Company is unable to raise additional capital, it
may be required to take additional measures to conserve liquidity,
which could include, but not necessarily be limited to suspending
the pursuit of a potential transaction. The Company cannot provide
any assurance that new financing will be available to it on
commercially acceptable terms, if at all. Even if the Company can
obtain sufficient financing or raise additional capital, it only
has until August 22, 2019 (or November 22,
2019, if the extension amendment is approved) to consummate
a Business Combination. There is no assurance that the Company will
be able to do so prior to August 22, 2019 (or November 22, 2019, if
the extension amendment is approved).
NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The
accompanying unaudited condensed financial statements have been
prepared in accordance with accounting principles generally
accepted in the United States of America (“GAAP”) for
interim financial information and in accordance with the
instructions to Form 10-Q and Article 8 of Regulation S-X of the
Securities and Exchange Commission (the “SEC”). Certain
information or footnote disclosures normally included in financial
statements prepared in accordance with GAAP have been condensed or
omitted, pursuant to the rules and regulations of the SEC for
interim financial reporting. Accordingly, they do not include all
the information and footnotes necessary for a comprehensive
presentation of financial position, results of operations, or cash
flows. In the opinion of management, the accompanying unaudited
condensed financial statements include all adjustments, consisting
of a normal recurring nature, which are necessary for a fair
presentation of the financial position, operating results and cash
flows for the periods presented.
The
accompanying unaudited condensed financial statements should be
read in conjunction with the Company’s Annual Report on Form
10-K for the year ended December 31, 2018 as filed with the SEC on
March 15, 2019, which contains the audited financial statements and
notes thereto. The interim results for the three and six months
ended June 30, 2019 are not necessarily indicative of the results
to be expected for the year ending December 31, 2019 or for any
future interim periods.
Use of estimates
The
preparation of condensed financial statements in conformity with
GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
condensed financial statements and the reported amounts of revenues
and expenses during the reporting period.
6
BIG ROCK PARTNERS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2019
(Unaudited)
Making
estimates requires management to exercise significant judgment. It
is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the
date of the financial statements, which management considered in
formulating its estimate, could change in the near term due to one
or more future confirming events. Accordingly, the actual results
could differ significantly from the Company’s
estimates.
Cash and marketable securities held in Trust Account
At June
30, 2019 and December 31, 2018, the assets held in the Trust
Account were held in money market funds. During the six months
ended June 30, 2019, the Company withdrew $261,793 of interest
income to pay its franchise tax obligations.
Net loss per common share
Net
loss per common share is computed by dividing net income (loss) by
the weighted average number of common shares outstanding for the
period. The Company applies the two-class method in calculating
earnings per share. Shares of common stock subject to possible
redemption at June 30, 2019 and December 31, 2018, which are not
currently redeemable and are not redeemable at fair value, have
been excluded from the calculation of basic net loss per share
since such shares, if redeemed, only participate in their pro rata
share of the Trust Account earnings. The Company has not considered
the effect of (1) warrants sold in the Initial Public Offering and
private placement to purchase 3,586,250 shares of common stock, (2)
rights sold in the Initial Public Offering and private placement
that convert into 717,250 shares of common stock and (3) 600,000
shares of common stock, warrants to purchase 300,000 shares of
common stock and rights that convert into 60,000 shares of common
stock in the unit purchase option sold to the underwriter, in the
calculation of diluted loss per share, since the exercise of the
warrants, the conversion of the rights into shares of common stock
and the exercise of the unit purchase option are contingent upon
the occurrence of future events. As a result, diluted loss per
common share is the same as basic income per common share for the
periods presented.
Reconciliation of net loss per common share
The
Company’s net income (loss) is adjusted for the portion of
income that is attributable to common stock subject to possible
redemption, as these shares only participate in the earnings of the
Trust Account and not the income or losses of the Company.
Accordingly, basic and diluted loss per share is calculated as
follows:
|
Three Months
Ended June 30,
|
Six Months Ended
June 30,
|
||
|
2019
|
2018
|
2019
|
2018
|
Net income
(loss)
|
$176,021
|
$(6,602)
|
$363,986
|
$8,879
|
Less: Income
attributable to common stock subject to possible
redemption
|
(259,727)
|
(158,321)
|
(518,924)
|
(355,325)
|
Adjusted net
loss
|
$(83,706)
|
$(164,923)
|
$(154,938)
|
$(346,446)
|
|
|
|
|
|
Weighted average
shares outstanding, basic and diluted
|
2,794,297
|
2,605,782
|
2,759,859
|
2,598,424
|
|
|
|
|
|
Basic and diluted
net loss per common share
|
$(0.03)
|
$(0.06)
|
$(0.06)
|
$(0.13)
|
NOTE 4. INVESTOR AGREEMENT AND PROMISSORY NOTES
On
November 17, 2018, the Company entered into an Agreement with the
Sponsor and the Investor. Pursuant to the Agreement, the Sponsor
transferred an aggregate of 1,500,000 Founders Shares (as defined
in Note 5) to the Investor in exchange for the agreements set forth
below and aggregate cash consideration of $1.00.
Pursuant to the
Agreement, the Sponsor agreed to extend the period of time the
Company has to consummate a Business Combination up to two times
for an aggregate of up to six months and the Investor agreed to
loan the Company the funds necessary to obtain the extensions (the
Extensions”). On November 20, 2018 and February 21, 2019, the
Company issued unsecured promissory notes (the “Notes”)
in favor of the Investor, in the original principal amount of
$690,000 each (or an aggregate of $1,380,000), to provide the
Company the funds necessary to obtain an aggregate of six-month
Extensions. Pursuant to the Agreement, the Investor has also agreed
to loan the Company all funds necessary to pay expenses incurred in
connection with and in order to consummate a Business Combination
(the “Business Combination Expenses”) and such loans
will be added to the Notes. If the Company does not consummate a
Business Combination, all outstanding loans under the Notes will be
forgiven, except to the extent of any funds held outside of the
Trust Account after paying all other fees and expenses of the
Company incurred prior to the date of such failure to consummate a
Business Combination. As of June 30, 2019, the outstanding balance
under the Notes amounted to an aggregate of
$1,380,000.
7
BIG ROCK PARTNERS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2019
(Unaudited)
The
Sponsor has agreed to be responsible for all liabilities of the
Company as of November 17, 2018, except for liabilities associated
with the possible redemption of shares by the Company’s
shareholders, as described in the Company’s Amended and
Restated Certificate of Incorporation. The Sponsor has also agreed
to loan the Company the funds necessary to pay the expenses of the
Company other than the Business Combination Expenses through the
closing of a Business Combination when and as needed in order for
the Company to continue in operation (the “Non-Business
Combination Related Expenses”). Upon consummation of a
Business Combination, up to $200,000 of the Non-Business
Combination Related Expenses will be repaid by the Company to the
Sponsor provided that the Company has funds available to it
sufficient to repay such expenses (the “Cap”) as well
as to pay for all stockholder redemptions, all Business Combination
Expenses, repayment of the Notes, and any funds necessary for the
working capital requirements of the Company following closing of
the Business Combination. Any remaining amounts in excess of the
Cap will be forgiven. If the Company does not consummate a Business
Combination, all outstanding loans made by the Sponsor to cover the
Non-Business Combination Related Expenses will be forgiven. At June
30, 2019, the outstanding balance under this loan amounted to
$206,865.
NOTE 5. COMMITMENTS AND CONTINGENCIES
Registration Rights
Pursuant to a
registration rights agreement entered into on November 20, 2017,
the holders of the Company’s common stock prior to the
Initial Public Offering (the “Founder Shares”), Private
Placement Units (and their underlying securities), the shares
issued to EarlyBirdCapital, Inc. (“EarlyBirdCapital”)
at the closing of the Initial Public Offering (the
“Representative Shares”) and any Units that may be
issued upon conversion of the working capital loans (and their
underlying securities) are entitled to registration rights. The
holders of a majority of these securities are entitled to make up
to three demands, excluding short form demands, that the Company
register such securities. The holders of the majority of the
Founder’s Shares can elect to exercise these registration
rights at any time commencing three months prior to the date on
which these shares of common stock are to be released from escrow.
The holders of a majority of the Private Placement Units or Units
issued to the Sponsor, officers, directors or their affiliates in
payment of working capital loans made to the Company (in each case,
including the underlying securities) can elect to exercise these
registration rights at any time after the Company consummates a
Business Combination. In addition, the holders will have certain
“piggy-back” registration rights with respect to
registration statements filed subsequent to the completion of a
Business Combination and rights to require the Company to register
for resale such securities pursuant to Rule 415 under the
Securities Act of 1933, as amended (the “Securities
Act”). Notwithstanding anything to the contrary,
EarlyBirdCapital and its designees may participate in a
“piggy-back” registration during the seven year period
beginning on the effective date of the registration statement.
However, the registration rights agreement will provide that the
Company will not permit any registration statement filed under the
Securities Act to become effective until termination of the
applicable lock-up period. The Company will bear the expenses
incurred in connection with the filing of any such registration
statements.
Business Combination Marketing Agreement
The
Company has engaged EarlyBirdCapital as an advisor in connection
with a Business Combination to assist the Company in holding
meetings with its stockholders to discuss a potential Business
Combination and the target business’ attributes, introduce
the Company to potential investors that are interested in
purchasing securities, assist the Company in obtaining stockholder
approval for the Business Combination and assist the Company with
its press releases and public filings in connection with a Business
Combination. The Company will pay EarlyBirdCapital a cash fee for
such services upon the consummation of a Business Combination in an
amount equal to 4.0% of the gross proceeds of the Initial Public
Offering (exclusive of any applicable finders’ fees which
might become payable). If a Business Combination is not consummated
for any reason, no fee will be due or payable.
NOTE 6. STOCKHOLDERS’ EQUITY
Preferred Stock
— The Company is authorized to issue 1,000,000 shares of
preferred stock with a par value of $0.001 per share with such
designation, rights and preferences as may be determined from time
to time by the Company’s Board of Directors. At June 30, 2019
and December 31, 2018, there were no shares of preferred stock
issued or outstanding.
Common Stock —
The Company is authorized to issue 100,000,000 shares of common
stock with a par value of $0.001 per share. Holders of the
Company’s common stock are entitled to one vote for each
share. At June 30, 2019 and December 31, 2018, there were 2,801,350
and 2,725,039, respectively, shares of common stock issued and
outstanding (excluding 4,114,378 and 6,310,461 shares of common
stock subject to possible redemption, respectively).
8
BIG ROCK PARTNERS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2019
(Unaudited)
NOTE 7. SUBSEQUENT EVENTS
The
Company evaluates subsequent events and transactions that occur
after the balance sheet date up to the date that the condensed
financial statements were issued. Other than as described below,
the Company did not identify any subsequent events that would have
required adjustment or disclosure in the condensed financial
statements.
In July
2019, the Company deposited $95,605 into the Trust Account for the
third, and final, 30-day extension period. The Company now has
until August 22, 2019 to consummate a Business Combination. In
order to pay for part of the third extension payment, the Company
issued an unsecured promissory note (the “Promissory
Note”) in favor of the Investor, in the original principal
amount of $6,814. The Note does not bear interest and matures upon
closing of a Business Combination by the Company. If the Company
fails to consummate a Business Combination, the outstanding debt
under the Note will be forgiven, except to the extent of any funds
held outside of the Company's Trust Account after paying all other
fees and expenses of the Company.
The
Company has scheduled a special meeting of stockholders for August
21, 2019, pursuant to which it will seek stockholder approval to,
among other matters, amend the Company’s Amended and Restated
Certificate of Incorporation to extend the period of time for which
the Company is required to consummate a Business Combination from
August 22, 2019 to November 22, 2019. There is no assurance that
the Company’s stockholders will vote to approve the extension
of time with which the Company has to complete a Business
Combination. If the Company does not obtain stockholder approval,
the Company would wind up its affairs and liquidate.
On
August 9, 2019, the Company received a notice from the Staff
stating that the Company was no longer in compliance with Nasdaq
Listing Rule 5550(a)(3) for continued listing due to its failure to
maintain a minimum of 300 public holders. The Company has
until
September 23, 2019 to provide Nasdaq with a specific plan to
achieve and sustain compliance with the listing requirement. The
notice is a notification of deficiency, not of imminent delisting,
and has no current effect on the listing or trading of the
Company's securities on Nasdaq.
The
Company intends to submit a plan to regain compliance within the
required timeframe. If Nasdaq accepts the Company's plan, Nasdaq
may grant the Company an extension of up to 180 calendar days from
the date of the notice to evidence compliance with the Rule. If
Nasdaq does not accept the Company's plan, the Company will have
the opportunity to appeal the decision in front of a Nasdaq
Hearings Panel.
9
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
References in this report to “we,” “us” or
the “Company” refer to Big Rock Partners Acquisition
Corp. References to our “management” or our
“management team” refer to our officers and directors,
and references to the “Sponsor” refer to Big Rock
Partners Sponsor, LLC, a company affiliated with our Chairman,
President and Chief Executive Officer. The following discussion and
analysis of the Company’s financial condition and results of
operations should be read in conjunction with the financial
statements and the notes thereto contained elsewhere in this
report. Certain information contained in the discussion and
analysis set forth below includes forward-looking statements that
involve risks and uncertainties
Special Note Regarding Forward-Looking Statements
This
Quarterly Report on Form 10-Q includes “forward-looking
statements” within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act that are not
historical facts, and involve risks and uncertainties that could
cause actual results to differ materially from those expected and
projected. All statements other than statements of historical fact
included in this Form 10-Q including statements in this
“Management’s Discussion and Analysis of Financial
Condition and Results of Operations” regarding the
Company’s financial position, business strategy and the plans
and objectives of management for future operations, are
forward-looking statements. Words such as “expect,”
“believe,” “anticipate,”
“intend,” “estimate,” “seek”
and variations and similar words and expressions are intended to
identify such forward-looking statements. Such forward-looking
statements relate to future events or future performance, but
reflect management’s current beliefs, based on information
currently available. A number of factors could cause actual events,
performance or results to differ materially from the events,
performance and results discussed in the forward-looking
statements. For information identifying important factors that
could cause actual results to differ materially from those
anticipated in the forward-looking statements, please refer to the
Risk Factors section of the Company’s Annual Report on Form
10-K for the year ending December 31, 2018 filed with the SEC on
March 15, 2019. The Company’s securities filings can be
accessed on the EDGAR section of the SEC’s website at
www.sec.gov. Except as expressly required by applicable securities
law, the Company disclaims any intention or obligation to update or
revise any forward-looking statements whether as a result of new
information, future events or otherwise.
Overview
We are
a blank check company incorporated in Delaware on September 18,
2017 and formed for the purpose of entering into a merger, share
exchange, asset acquisition, stock purchase, recapitalization,
reorganization or other similar business combination with one or
more target businesses or entities (a “Business
Combination”). While our efforts in identifying a prospective
target business for our initial Business Combination will not be
limited to a particular industry or geographic region, we intend to
initially focus our search on identifying a prospective target
business in the senior housing and care industry in the United
States. We intend to effectuate our Business Combination using cash
from the proceeds of our Initial Public Offering and the sale of
Private Placement Units that occurred simultaneously with the
completion of our Initial Public Offering, our securities, debt or
a combination of cash, securities and debt.
Recent
Developments
On
November 17, 2018, we entered into an agreement (the
“Agreement”) with the Sponsor and BRAC Lending Group
LLC (the “Investor”). Pursuant to the Agreement, the
Sponsor transferred an aggregate of 1,500,000 Founders Shares to
the Investor in exchange for the agreements set forth below and
aggregate cash consideration of $1.00. Pursuant to the Agreement,
the Sponsor agreed to take all actions reasonably necessary to
extend the period of time we have to consummate a Business
Combination up to two times for an aggregate of up to six months
and the Investor agreed to loan us the funds necessary to obtain
the extensions (the “Extension(s)”). On November 20,
2018, we issued an unsecured promissory note (the “First
Note”) in favor of the Investor, in the original principal
amount of $690,000, to provide us the funds necessary to obtain the
first three-month Extension. On November 20, 2018, we issued a
press release announcing that we had obtained the first three-month
Extension to complete a Business Combination from November 22, 2018
to February 22, 2019. On February 21, 2019, we issued a second
unsecured promissory note (the “Second Note, and together
with the First Note, the “Notes”) in favor of the
Investor, in the original principal amount of $690,000, to provide
us the funds necessary to obtain the second three-month Extension.
On February 22, 2019, we issued a press release announcing that we
had obtained the second three-month Extension to complete a
Business Combination from February 22, 2019 to May 22,
2019.
Pursuant
to the Agreement, the Investor has also agreed to loan us all funds
necessary to pay expenses incurred in connection with and in order
to consummate a Business Combination (the “Business
Combination Expenses”) and such loans will be added to the
Notes. Also, pursuant to the Agreement, the Sponsor has agreed to
be responsible for all our liabilities as of November 17, 2018,
except for liabilities associated with the possible redemption of
shares by our shareholders, as described in our Amended and
Restated Certificate of Incorporation. The Sponsor has also agreed
to loan us the funds necessary to pay our expenses other than the
Business Combination Expenses through the closing of a Business
Combination when and as needed in order for us to continue in
operation (the “Non-Business Combination Related
Expenses”). Upon consummation of a Business Combination, up
to $200,000 of the Non-Business Combination Related Expenses will
be repaid by us to the Sponsor provided that we have funds
available to us sufficient to repay such expenses (the
“Cap”) as well as to pay for all stockholder
redemptions, all Business Combination Expenses, repayment of the
Note, and any funds necessary for our working capital requirements
following closing of the Business Combination. Any remaining
amounts in excess of the Cap will be forgiven. If we do not
consummate a Business Combination, all outstanding loans made by
the Sponsor to cover the Non-Business Combination Related Expenses
will be forgiven.
10
The
Founder’s Shares transferred by the Sponsor to the Investor
will remain in escrow in the name of the Investor, subject to the
terms of the Stock Escrow Agreement, dated November 20, 2017, among
us, the Sponsor and Continental Stock Transfer & Trust Company.
Additionally, the Sponsor assigned the registration rights it was
granted, pursuant to the Registration Rights Agreement, dated
November 20, 2017 between us and the Sponsor, with respect to the
Founder’s Shares to the Investor in connection with the
transfer.
On May
21, 2019, our stockholders approved an amendment to our Amended and
Restated Certificate of Incorporation to extend the period of time
for which we are required to consummate a Business Combination to
August 22, 2019 (the “Extended Date”). The number of
shares of common stock presented for redemption in connection with
the extension was 2,119,772. We paid cash in the aggregate amount
of $22,099,233, or approximately $10.43 per share, to redeeming
stockholders. We agreed to deposit, or cause to be deposited on our
behalf, into the Trust Account $0.02 for each public share
outstanding for each 30-day extension period utilized through the
Extended Date. Through June 30, 2019, we deposited an aggregate of
$286,814 into the Trust Account, of which $191,209 was contributed
to the Trust Account by a third party and is not required to be
repaid by us. In July 2019, we deposited an additional $95,605 into
the Trust Account for the third, and final, 30-day extension
period. We now have until August 22, 2019 to consummate a Business
Combination. In order to pay for part of the third extension
payment, we issued an unsecured promissory note (the
“Note”) in favor of the Investor, in the original
principal amount of $6,814. The Note does not bear interest and
matures upon closing of a Business Combination. If we fail to
consummate a Business Combination, the outstanding debt under the
Note will be forgiven, except to the extent of any funds held
outside of the Trust Account after paying all of our other fees and
expenses.
We have
scheduled a special meeting of stockholders for August 21, 2019,
pursuant to which we will seek stockholder approval to, among other
matters, amend our Amended and Restated Certificate of
Incorporation to extend the period of time for which we are
required to consummate a Business Combination from August 22, 2019
to November 22, 2019. There is no assurance that our stockholders
will vote to approve the extension of time with which we have to
complete a Business Combination. If we do not obtain stockholder
approval, we would wind up its affairs and liquidate.
On
August 9, 2019, we received a notice from the Staff stating that we
were no longer in compliance with Nasdaq Listing Rule 5550(a)(3)
for continued listing due to its failure to maintain a minimum of
300 public holders. We have until
September 23, 2019 to provide Nasdaq with a specific plan to
achieve and sustain compliance with the listing requirement. The
notice is a notification of deficiency, not of imminent delisting,
and has no current effect on the listing or trading of our
securities on Nasdaq.
We intend to submit a plan to regain compliance within the required
timeframe. If Nasdaq accepts our plan, Nasdaq may grant us an
extension of up to 180 calendar days from the date of the notice to
evidence compliance with the Rule. If Nasdaq does not accept our
plan, we will have the opportunity to appeal the decision in front
of a Nasdaq Hearings Panel.
Results of Operations
Our
entire activity since September 18, 2017 (inception) up to November
20, 2017 was in preparation for our Initial Public Offering. Since
our Initial Public Offering, our activity has been limited to the
search for a prospective initial Business Combination, and we will
not be generating any operating revenues until the closing and
completion of our initial Business Combination. We are incurring
expenses as a result of being a public company (for legal,
financial reporting, accounting and auditing compliance), as well
as for due diligence expenses.
For the
three months ended June 30, 2019, we had a net income of $176,021,
which consists of interest income on securities held in the trust
account established for the benefit of our public stockholders (the
“Trust Account”) of $392,439, offset by operating costs
of $175,742 and provision for income taxes of $40,676.
For the
six months ended June 30, 2019, we had a net income of $363,986,
which consists of interest income on securities held in the Trust
Account of $775,301, offset by operating costs of $338,923 and
provision for income taxes of $72,392.
For the
three months ended June 30, 2018, we had a net loss of $6,602,
which consists of operating costs of $271,810 and a provision for
income taxes of $8,948, offset by interest income on marketable
securities held in the Trust Account of $272,482 and an unrealized
gain on marketable securities held in the Trust Account of
$1,674.
For the
six months ended June 30, 2018, we had net income of $8,879, which
consists of interest income on marketable securities held in the
Trust Account of $486,051 and an unrealized gain on marketable
securities held in the Trust Account of $75, offset by operating
costs of $464,184 and a provision for income taxes of
$13,063.
Liquidity and Capital Resources
As of
June 30, 2019, we had cash and marketable securities held in the
Trust Account of $50,061,450 (including approximately $1,112,000 of
interest income) consisting of money market funds. Interest income
earned on the balance in the Trust Account may be used by us to pay
taxes. To date, we have withdrawn approximately $304,000 of
interest from the Trust Account in order to pay our income and
franchise taxes, of which approximately $262,000 was withdrawn
during the six months ended June 30, 2019.
For the
six months ended June 30, 2019, cash used in operating activities
amounted to $478,343. Net income of $363,986 was the result of
interest earned on securities held in the Trust Account of
$775,301, offset by changes in operating assets and liabilities,
which used $67,028 of cash for operating
activities.
For the
six months ended June 30, 2018, cash used in operating activities
amounted to $334,900. Net income of $8,879 was impacted by interest
earned on marketable securities held in the Trust Account of
$486,051 and an unrealized gain on marketable securities held in
our Trust Account of $75. Changes in operating assets and
liabilities provided $142,347 of cash for operating
activities.
11
We
intend to use substantially all of the net proceeds of the Initial
Public Offering, including the funds held in the Trust Account, to
acquire a target business or businesses and to pay our expenses
relating thereto. To the extent that our capital stock is used, in
whole or in part, as consideration to effect our Business
Combination, the remaining proceeds held in the Trust Account, as
well as any other net proceeds not expended, will be used as
working capital to finance the operations of the target business.
Such working capital funds could be used in a variety of ways
including, but not limited to, continuing or expanding the target
business’ operations, for strategic acquisitions and for
marketing, research and development of existing or new products.
Such funds could also be used to repay any expenses or
finders’ fees which we had incurred prior to the completion
of our Business Combination if the funds available to us outside of
the Trust Account were insufficient to cover such
expenses.
As of
June 30, 2019, the Sponsor has loaned us an aggregate of $206,865
in order to pay our Non-Business Combination Related Expenses. Upon
consummation of a Business Combination, up to $200,000 of the
Non-Business Combination Related Expenses will be repaid by us to
the Sponsor provided that we have funds available to us sufficient
to repay such expenses (the “Cap”) as well as to pay
for all stockholder redemptions, all Business Combination Expenses,
repayment of the Note, and any funds necessary for our working
capital requirements following closing of the Business Combination.
Any remaining amounts in excess of the Cap will be forgiven. If we
do not consummate a Business Combination, all outstanding loans
made by the Sponsor to cover the Non-Business Combination Related
Expenses will be forgiven.
We do
not believe we will need to raise additional funds in order to meet
expenditures required for operating our business. However, if our
estimate of the costs of identifying a target business, undertaking
in-depth due diligence and negotiating a Business Combination are
less than the actual amounts necessary to do so, we may have
insufficient funds available to operate our business prior to our
Business Combination. In order to fund working capital deficiencies
or finance transaction costs in connection with a Business
Combination, our Sponsor, officers and directors or their
respective affiliates may, but are not obligated to, except as
described above, loan us funds as may be required. If we complete a
Business Combination, we would repay such loaned amounts out of the
proceeds of the Trust Account released to us. In the event that a
Business Combination does not close, we may use a portion of the
working capital held outside the Trust Account to repay such loaned
amounts but no proceeds from our Trust Account would be used for
such repayment. Up to $1,500,000 of such loans may be convertible
into units, at a price of $10.00 per unit at the option of the
lender. The units would be identical to the Private Placement
Units.
Moreover,
we may need to obtain additional financing either to complete our
Business Combination or because we become obligated to redeem a
significant number of our public shares upon completion of our
Business Combination, in which case we may issue additional
securities or incur debt in connection with such Business
Combination. Subject to compliance with applicable securities laws,
we would only complete such financing simultaneously with the
completion of our Business Combination. If we are unable to
complete our Business Combination because we do not have sufficient
funds available to us, we will be forced to cease operations and
liquidate the Trust Account. In addition, following our Business
Combination, if cash on hand is insufficient, we may need to obtain
additional financing in order to meet our obligations.
Off-balance sheet financing arrangements
We did
not have any off-balance sheet arrangements as of June 30,
2019.
Contractual obligations
We do
not have any long-term debt, capital lease obligations, operating
lease obligations or long-term liabilities.
Critical Accounting Policies
The
preparation of financial statements and related disclosures in
conformity with accounting principles generally accepted in the
United States of America requires management to make estimates and
assumptions that affect the reported amounts of assets and
liabilities, disclosure of contingent assets and liabilities at the
date of the financial statements, and income and expenses during
the periods reported. Actual results could materially differ from
those estimates. We have identified the following critical
accounting policies:
Common stock subject to possible redemption
We
account for our common stock subject to possible redemption in
accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities
from Equity.” Common stock subject to mandatory redemption is
classified as a liability instrument and is measured at fair value.
Conditionally redeemable common stock (including common stock that
features redemption rights that are either within the control of
the holder or subject to redemption upon the occurrence of
uncertain events not solely within our control) is classified as
temporary equity. At all other times, common stock is classified as
stockholders’ equity. Our common stock features certain
redemption rights that are considered to be outside of our control
and subject to occurrence of uncertain future events. Accordingly,
common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the
stockholders’ equity section of our balance
sheets.
12
Net loss per common share
We
apply the two-class method in calculating earnings per share.
Shares of common stock subject to possible redemption which are not
currently redeemable and are not redeemable at fair value, have
been excluded from the calculation of basic net loss per share
since such shares, if redeemed, only participate in their pro rata
share of the trust account earnings. Our net income is adjusted for
the portion of income that is attributable to common stock subject
to possible redemption, as these shares only participate in the
earnings of the Trust Account and not our income or
losses.
Recent accounting pronouncements
Management
does not believe that any recently issued, but not yet effective,
accounting pronouncements, if currently adopted, would have a
material effect on our financial statements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
Following
the consummation of our Initial Public Offering, we invested the
funds held in the Trust Account in money market funds meeting
certain conditions under Rule 2a-7 under the Investment Company
Act, which invest solely in United States Treasuries. Due to these
short-term nature of the investments, we do not believe that there
will be an associated material exposure to interest rate
risk.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure
controls and procedures are controls and other procedures that are
designed to ensure that information required to be disclosed in our
reports filed or submitted under the Exchange Act is recorded,
processed, summarized and reported within the time periods
specified in the SEC’s rules and forms. Disclosure controls
and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed in our
reports filed or submitted under the Exchange Act is accumulated
and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, to allow timely decisions
regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As
required by Rules 13a-15 and 15d-15 under the Exchange Act, our
Chief Executive Officer and Chief Financial Officer carried out an
evaluation of the effectiveness of the design and operation of our
disclosure controls and procedures as of June 30, 2019. Based upon
their evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures (as
defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act)
were effective as of June 30, 2019.
Changes in Internal Control Over Financial Reporting
During
the most recently completed fiscal quarter, there has been no
change in our internal control over financial reporting that has
materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.
13
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 1A. RISK FACTORS
Factors
that could cause our actual results to differ materially from those
in this report include the risk factors described in our Annual
Report on Form 10-K for the year ended December 31, 2018 filed with
the SEC on March 15, 2019. As of the date of this Report, there
have been no material changes to the risk factors disclosed in our
Annual Report filed with the SEC.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
On May 21, 2019, the
Company’s stockholders approved to amend its Amended and
Restated Certificate of Incorporation to extend the period of time
for which the Company is required to consummate a Business
Combination to August 22, 2019. The number of shares of common
stock presented for redemption in connection with the extension was
2,119,772. The Company paid cash in the aggregate amount of
$22,099,233, or approximately $10.43 per share, to redeeming
stockholders. For additional information, see Note 1 to the
condensed financial statements.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not
applicable.
ITEM 5. OTHER INFORMATION
None.
14
ITEM 6. EXHIBITS
The
following exhibits are filed as part of this Quarterly Report on
Form 10-Q.
No.
|
|
Description of Exhibit
|
|
Amendment to Amended and Restated Certificate of Incorporation
(incorporated by reference to Exhibit 3.1 to the Company’s
Form 8-K, filed on May 22, 2019)
|
|
31.1 *
|
|
Certification
of Principal Executive Officer Pursuant to Securities Exchange Act
Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302
of the Sarbanes-Oxley Act of 2002
|
31.2 *
|
|
Certification
of Principal Financial Officer Pursuant to Securities Exchange Act
Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302
of the Sarbanes-Oxley Act of 2002
|
32.1 **
|
|
Certification
of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350,
as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
32.2 **
|
|
Certification
of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350,
as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
101.INS*
|
|
XBRL
Instance Document
|
101.CAL*
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
101.SCH*
|
|
XBRL
Taxonomy Extension Schema Document
|
101.DEF*
|
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
101.LAB*
|
|
XBRL
Taxonomy Extension Labels Linkbase Document
|
101.PRE*
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
*
|
Filed
herewith.
|
**
|
Furnished.
|
15
SIGNATURES
Pursuant to the
requirements of Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
BIG ROCK PARTNERS ACQUISITION CORP.
|
|
|
|
|
Date:
August 14, 2019
|
By:
|
/s/
Richard Ackerman
|
|
|
Name:
Richard Ackerman
|
|
|
Title:
Chairman, President and Chief Executive Officer
|
|
|
(Principal
Executive Officer)
|
|
|
|
|
|
|
Date:
August 14, 2019
|
By:
|
/s/
Lori B. Wittman
|
|
|
Name:
Lori B. Wittman
|
|
|
Title:
Chief Financial Officer and Director
|
|
|
(Principal
Financial and Accounting Officer)
|
16